Simon Lowth - Articles and news items


Simon Lowth, Chief Financial Officer, to leave AstraZeneca

Industry news, News / 15 July 2013 / AstraZeneca

AstraZeneca announced that Simon Lowth, CFO and Executive Director, will leave the company at the end of October…


AstraZeneca and Bristol-Myers Squibb complete expansion of diabetes alliance

Industry news, News / 9 August 2012 / AstraZeneca

AstraZeneca has made an initial payment of approximately $3.2 billion to Amylin Pharmaceuticals…

David Brennan, CEO, AstraZeneca

David Brennan to retire as AstraZeneca’s Chief Executive Officer

Industry news, News / 26 April 2012 / AstraZeneca

AstraZeneca announced that Chief Executive Officer and Board member, David Brennan has decided to retire…


AstraZeneca commits an additional $100 million to venture capital arm MedImmune Ventures

Industry news, News / 28 November 2011 / AstraZeneca

MedImmune Ventures closes investment in Australian company, NeuProtect Pty Ltd…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...